^
Association details:
Biomarker:No biomarker
Cancer:Mesothelioma
Drug:pemetrexed (Thymidylate synthase inhibitor, THF dehydrogenase inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
Malignant Peritoneal Mesothelioma…SUBSEQUENT SYSTEMIC THERAPY…Preferred…Pemetrexed (if not considered as first-line)…